Metabolic Syndrome (MetS) and Nonalcoholic Steatohepatitis (NASH): Study of biochemical markers Free Fatty Acid (FFA), Total Antioxidant Status (TAOS), Adiponectin, Transforming Growth Factor (TGF-beta1), in occurence of NASH
BACKGROUND: The prevalence of metabolic syndrome (MetS) in USA and Makassar are 22% and 23.7%. The prevalence of Non Alcoholic Steatosis Hepatosis (NASH) in MetS has not been reported. Study in Non-alcoholic Fatty Liver Disease (NAFLD) is 25–90 % in obesity patients. In NASH, there is accumulation o...
Main Authors: | Agus Sulaeman, A Rifai Amiruddin, Gatot Susilo Lawrence |
---|---|
Format: | Article |
Language: | English |
Published: |
Secretariat of The Indonesian Biomedical Journal
2009-04-01
|
Series: | Indonesian Biomedical Journal |
Online Access: | http://inabj.org/index.php/ibj/article/view/81 |
Similar Items
-
Nonalcoholic steatohepatitis (NASH) : animal studies of interactive hepatoxicity
by: Clarkson, Vivian
Published: (2014) -
Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
by: D.N. Amarapurkar, et al.
Published: (2006-01-01) -
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01) -
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
by: Feryal Savari, et al.
Published: (2019-07-01) -
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
by: Ozlem Kutlu, et al.
Published: (2018-01-01)